• Explore /
  • Poster
  • / Perioperative chemoimmunotherapy with durvalumab (Durva) in combination with cisplatin/gemcitabine (Cis/Gem) for operable muscle-invasive urothelial carcinoma (MIUC): Preplanned interim analysis of a single-arm phase II trial (SAKK 06/17).

Perioperative chemoimmunotherapy with durvalumab (Durva) in combination with cisplatin/gemcitabine (Cis/Gem) for operable muscle-invasive urothelial carcinoma (MIUC): Preplanned interim analysis of a single-arm phase II trial (SAKK 06/17).

Abstract Poster

Authors

null

Richard Cathomas

Department of Oncology, Cantonal Hospital Graubünden, Chur, Switzerland

Richard Cathomas , Ulf Petrausch , Stefanie Hayoz , Martina Schneider , Julian Andreas Schardt , Roland Seiler , Andreas Erdmann , Sacha Rothschild , Stefanie Aeppli , Nicolas Mach , Raeto Strebel , Boris A. Hadaschik , Dominik R. Berthold , Miklos Pless , Deborah Zihler , Mathias Schmid , Christine Biaggi Rudolf , Martin Spahn

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers

Track

Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

2017-003565-10

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 499)

Abstract #

499

Poster Bd #

H22

Abstract Disclosures

Similar Posters

First Author: Hailiang Zhang

First Author: Richard Cathomas

First Author: Guru P. Sonpavde

First Author: Sacha Rothschild